Home
RETURN TO ISLB.INFO MEMBERSHIP SUPPORT
HOME / PODCAST
| Nov 30, 1999

Population Implementation Progress Based on K-LUCAS Korean Trial

Victoria Lai
USA
Victoria Lai  
Speaker of: Population Implementation Progress Based on K-LUCAS Korean Trial
Victoria Lai is an assistant attending at Memorial Sloan Kettering with a research and clinical focus on small cell lung lung cancer and other pulmonary neuroendocrine malignancies.
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ISLB. The mention of any product, service, organization, activity, or therapy should not be construed as an ISLB endorsement.

Recent Episodes

Oct 04, 2026
ISLB Podcast
Oct 02, 2026
Global MTB Education Series 2026
Jun 30, 2026
Live Q&A Session
David Gandara, Christian Rolfo, Umberto Malapelle
May 21, 2026
Precision Medicine Overview & Liquid Biopsy
Christian Rolfo
May 21, 2026
Pathology & Methodology
Umberto Malapelle
May 21, 2026
Clinical Application & Case Studies
David Gandara
Nov 02, 2025
Preferred Oral Session
Nov 02, 2025
Closing Ceremony
Nov 01, 2025
New Clinical Applications in Advanced Stage Cancer #2
Nov 01, 2025
Decoding the Circulating Tumor Ecosystem: Multi Analyte Liquid Biopsy Unveiling Immune Dynamics, Dormancy and Platelet Crosstalk
Nov 01, 2025
Clinical Session - Neo Adjuvant, Adjuvant / MRD
Nov 01, 2025
Young Career Session: One Drop, Two Points of View: Clinical and Biological Perspectives in Liquid Biopsy
Oct 31, 2025
Opening Ceremony
Oct 31, 2025
New Clinical Applications in Advanced Stage Cancer #1
Oct 31, 2025
Improving Sensitivity in Liquid Biopsy for Early Cancer Detection
Oct 31, 2025
Stakeholder Workshop
Oct 31, 2025
Awards Lecture
Oct 31, 2025
Virtual Congress 2025 Posters
Nov 25, 2024
Best Abstract Award & Closing Ceremony
Nov 25, 2024
S09. Accreditations and Minimal Requirements for Liquid Biopsy
Nov 25, 2024
OA01. Preferred Abstracts
Nov 25, 2024
Industry Symposium: OneCell Diagnostics
Nov 24, 2024
Young Career Round Tables
Nov 24, 2024
Industry Symposium: Thermo Fisher Scientific
Nov 24, 2024
S08. Keynote Session
Nov 24, 2024
S07. Future Perspectives in Liquid Biopsy
Nov 24, 2024
Workshop: ctDNA : Preanalytical and Post Analytical Standardization Workshop
Nov 24, 2024
Industry Symposium: Foundation Medicine
Nov 24, 2024
S05. Liquid Biopsy for Early Cancer Detection
Nov 24, 2024
S06. Next Generation Technologies in Liquid Biopsy
Nov 24, 2024
Industry Symposium: Guardant Health
Nov 23, 2024
Opening Ceremony
Nov 23, 2024
S04. Award Lectures
Nov 23, 2024
Stakeholder Workshop
Nov 23, 2024
Industry Symposium: Precision Cancer Consortium
Nov 23, 2024
S02. Navigating the Complex Landscape of Liquid Biopsy: Current Trends and Future Directions
Nov 23, 2024
S03. Extracellular Vesicles and CTCs
Nov 23, 2024
S01. Current Status of Circulating Tumor DNA in Selected Solid Tumors
Oct 31, 2024
Virtual Congress 2024 Posters
Mar 13, 2024
Clinical Cases - Bonus Content
Mar 13, 2024
Meet the Vendors - Bonus Content
Mar 13, 2024
Clinical Applications
Mar 13, 2024
Bioinformatic
Nov 21, 2023
Best Abstract Award & Closing
Nov 21, 2023
Molecular Tumor Boards: Liquid Biopsy Case Discussions
Nov 21, 2023
Stakeholder Workshop
Nov 21, 2023
Liquid Biopsy (in Diagnosis and Therapeutic Decision-making) for Rare Malignancies (Track D)
Nov 21, 2023
Integrating Liquid Biopsy into Composite Biomarkers (Track E)
Nov 21, 2023
ISLB Award Lectures
Nov 21, 2023
ISS05 - Roche & Foundation Medicine
Nov 20, 2023
Preferred Abstracts
Nov 20, 2023
Liquid Biopsy in MRD Assessment (Track C)
Nov 20, 2023
Liquid Biopsy Implementation in Emerging Countries
Nov 20, 2023
Opening Ceremony
Nov 20, 2023
ISS03 - Novartis
Nov 20, 2023
Liquid Biopsy in Clinical Practice: SOC and New Indications (2022-2023) (Track A)
Nov 20, 2023
Next Generation Technologies in Liquid Biopsy (Track B)
Nov 20, 2023
Liquid Biopsy in Cancer Interception, Screening & Early Diagnosis
Nov 19, 2023
Liquid Biopsy Beyond Cancer (e.g Infectious Disease, Fetal)
Nov 19, 2023
Young Committee Career Session
Oct 31, 2023
Virtual Congress 2023 Posters
Oct 12, 2023
Predictive Molecular Pathology in Solid Tumors
Jul 08, 2023
Precision Oncology
Oct 22, 2022
Bio-Rad - The Genesis System and Celselect Slide™ Technology
Oct 22, 2022
Day 3
Oct 21, 2022
Day 2
Oct 20, 2022
Day 1
Oct 20, 2022
Virtual Congress 2022 Posters
Aug 11, 2022
Virtual Congress 2020
Aug 11, 2022
Addressing Unmet Needs for Predictive Immuno-Oncology Biomarkers
Apr 13, 2021
Topic 1 Presentation 2
Siddhartha Devarakonda
Apr 12, 2021
Topic 1 Presentation
Benjamin Drapkin
Nov 30, 1999
4ITLR LC Implementation After 10-years NELSON Follow Up Results
Samir Hanash
Nov 30, 1999
Lessons Learnt from LC Screening Studies Worldwide Towards Optimal Implementation
Nov 30, 1999
Poland: Interim Results of the National Pilot Lung Cancer Screening Program
David MacPherson
Nov 30, 1999
Lung Cancer Screening in Russia
Benjamin Lok
Nov 30, 1999
Shared Decision Aid
Kathryn Tully
Nov 30, 1999
Optimal Diagnostic Decision Algorithms
Yves Pommier
Nov 30, 1999
Health Connect: The New Zealand/Atlantic Canada Cancer Screening Project
Kate Sutherland
Nov 30, 1999
Lung Cancer Screening in the Times of Respiratory Infections
Nov 30, 1999
B3 Early Detection in EU 4iLTR Study Screening of Lung Cancer, Cardiovascular Disease and COPD in One Test
Portia Thomas
Nov 30, 1999
Reconstruction Protocols Software Vendor Performance
JT Poirier
Nov 30, 1999
China: The NELCIN B3 trial
Prasad Kopparapu
Nov 30, 1999
USA: Population Implementation. Report on the First Million Screens in the ACR Lung Cancer Screening Registry
Simon Heeke
Nov 30, 1999
Acquisition Protocols and Minimal Dose Requirements
Luis Paz-Ares
Nov 30, 1999
Screening Implementation in Middle - and Low-income Countries
Dominic Rothwell
Nov 30, 1999
The Grail Study
Kwok-Kin Wong
Nov 30, 1999
Outline of Screening Implementation in Japan
Jane Johnson
Nov 30, 1999
Go2Foundation: National Network of Screening Centers of Excellence
Bernd Giebel
Nov 30, 1999
Maine Health, Maine Medical Center Lung Screening Program Patient Education Tool (NNE-CTR Conference)
Bruno Paiva
Nov 30, 1999
The Added Value of Biomarkers for Individual Risk Profile
Katie Maher
Nov 30, 1999
Taiwan: Moving Beyond TALENT
Abbie Ireland
Nov 30, 1999
Population Implementation Progress Based on K-LUCAS Korean Trial
Victoria Lai
Nov 30, 1999
Development and Validation of a Protein Biomarker Panel in the Lung Cancer Cohort Consortium
Catherine Meador
Nov 30, 1999
Quality Control: Phantom Testing and Optimal CT Performance
Taofeek Owonikoko
Nov 30, 1999
Screening in the US Post Nelson
Alvaro Quintanal Villalonga
Nov 30, 1999
Lung Cancer Screening in Patients who Never Smoked
Triparna Sen
Nov 30, 1999
Early Detection of Coronary Artery Calcification
Roman Thomas
Nov 30, 1999
The Added Value of Biomarkers for Individual Risk Profile
Katie Maher
Nov 30, 1999
Lung Cancer Screening and Smoking Cessation Clinical Trials (SCALE) Collaboration (NIH Study)
Carmen Garrido
Nov 30, 1999
Israel: A New Lung Cancer Pilot in Soroka Hospital
Matthew Oser
Nov 30, 1999
Lung Cancer Screening in Canada
Kristin Higgins
Nov 30, 1999
England: The NHS Lung Health Checks
Ticiana Leal
Nov 30, 1999
Italy: The BioMILD and SMILE Study Results
Johathan Lehman
Nov 30, 1999
Lobectomy vs Sublobar Resection
Johathan Lehman
Nov 30, 1999
Sex Differences in Lung Cancer Screening
Julien Sage
Nov 30, 1999
Croatia: Starting a New Screening Program from Scratch
Trudy Oliver
Nov 30, 1999
New Prospects of Chemoprevention - Handout and Video are no longer available due to presented information being confidential.
Heather Wakelee
Nov 30, 1999
Diagnostic Workup After Referral
Natasha Rekhtman
Nov 30, 1999
Cost-effectiveness of European Implementation
Nitin Roper
Nov 30, 1999
Ambient Air Pollution Exposures: Individual Lung Cancer Risk Assessment
Charlie Rudin
Nov 30, 1999
Patient Perspective on CT Lung Screening
Humsa Venkatesh
Nov 30, 1999
Early Detection of Interstitial and Obstructive Lung Diseases
Anish Thomas
Nov 30, 1999
Stereotactic Ablative Radiotherapy (SABR/SBRT)
Silvia von Karstedt
HAVE A QUESTION?

Thank you for viewing thie presentation. Please share your feedback through this survey.

Click Here
Enrollment Required

Please register for this product - Access to teaching courses are only available to those that selected the additional option at the time of registration. You can still purchase access to these courses through this link

After enrollment, please log out and log back into the library.



Welcome to the IAPCO Web-EDGE Library

Please select from the options below in order to continue

Returning User

Select your name from the drop down list

New User

Require CMP Points?

My CMP Email is the same one as above



Enter
Error, missing field above
X